BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11705944)

  • 1. Phase variation among major surface antigens of Mycoplasma penetrans.
    Röske K; Blanchard A; Chambaud I; Citti C; Helbig JH; Prevost MC; Rosengarten R; Jacobs E
    Infect Immun; 2001 Dec; 69(12):7642-51. PubMed ID: 11705944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycoplasma penetrans infections and seroconversion in patients with AIDS: identification of major mycoplasmal antigens targeted by host antibody response.
    Lo SC; Wang RY; Grandinetti T; Zou N; Hayes MM; Shih JW; Wear DJ
    FEMS Immunol Med Microbiol; 2005 Jun; 44(3):277-82. PubMed ID: 15907449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic characterization and cytolocalization of P35, the major Mycoplasma penetrans antigen.
    Neyrolles O; Eliane JP; Ferris S; Ayr Florio da Cunha R; Prevost MC; Bahraoui E; Blanchard A
    Microbiology (Reading); 1999 Feb; 145 ( Pt 2)():343-355. PubMed ID: 10075417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple promoter inversions generate surface antigenic variation in Mycoplasma penetrans.
    Horino A; Sasaki Y; Sasaki T; Kenri T
    J Bacteriol; 2003 Jan; 185(1):231-42. PubMed ID: 12486060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity.
    Neyrolles O; Chambaud I; Ferris S; Prevost MC; Sasaki T; Montagnier L; Blanchard A
    Infect Immun; 1999 Apr; 67(4):1569-78. PubMed ID: 10084988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of Mycoplasma hominis.
    Ladefoged SA
    APMIS Suppl; 2000; 97():1-45. PubMed ID: 10721331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase and size variable surface-exposed proteins in equine genital mycoplasmas.
    Tortschanoff M; Aurich C; Rosengarten R; Spergser J
    Vet Microbiol; 2005 Oct; 110(3-4):301-6. PubMed ID: 16143468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic heterogeneity in Mycoplasma iowae demonstrated with monoclonal antibodies.
    Panangala VS; Gresham MM; Morsy MA
    Avian Dis; 1992; 36(1):108-13. PubMed ID: 1373600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a Mycoplasma penetrans expression library in E. coli using the two-phase expression system.
    Yan ZX; Andreev J; Rottem S; Meyer TF
    Behring Inst Mitt; 1997 Feb; (98):99-102. PubMed ID: 9382775
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of IgG, IgM, and IgA antibodies to mycoplasma penetrans detected by ELISA and immunoblot in HIV-1-infected and STD patients, in São Paulo, Prazil.
    de Cordova CM; Takei K; Rosenthal C; Miranda MA; Vaz AJ; da Cunha RA
    Microbes Infect; 1999 Nov; 1(13):1095-101. PubMed ID: 10572313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigenic variation in Mycoplasmas].
    Rivera-Tapia JA
    Gac Med Mex; 2002; 138(3):289-90. PubMed ID: 12102047
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycoplasma hominis lipid-associated membrane protein antigens for effective detection of M. hominis-specific antibodies in humans.
    Lo SC; Wang RY; Grandinetti T; Zou N; Haley CL; Hayes MM; Wear DJ; Shih JW
    Clin Infect Dis; 2003 May; 36(10):1246-53. PubMed ID: 12746769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrachromosomal recombination within the vsp locus of Mycoplasma bovis generates a chimeric variable surface lipoprotein antigen.
    Lysnyansky I; Ron Y; Sachse K; Yogev D
    Infect Immun; 2001 Jun; 69(6):3703-12. PubMed ID: 11349034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complete genomic sequence of Mycoplasma penetrans, an intracellular bacterial pathogen in humans.
    Sasaki Y; Ishikawa J; Yamashita A; Oshima K; Kenri T; Furuya K; Yoshino C; Horino A; Shiba T; Sasaki T; Hattori M
    Nucleic Acids Res; 2002 Dec; 30(23):5293-300. PubMed ID: 12466555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of Mycoplasma.
    Christiansen G; Jensen LT; Boesen T; Emmersen J; Ladefoged SA; Schiøtz LK; Birkelund S
    Wien Klin Wochenschr; 1997 Aug; 109(14-15):557-61. PubMed ID: 9286059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.
    Shimizu T; Kida Y; Kuwano K
    Immunology; 2004 Sep; 113(1):121-9. PubMed ID: 15312143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and analysis of a stable serotype-associated membrane protein (P30) of Mycoplasma agalactiae.
    Fleury B; Bergonier D; Berthelot X; Schlatter Y; Frey J; Vilei EM
    J Clin Microbiol; 2001 Aug; 39(8):2814-22. PubMed ID: 11473997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by lipid-associated membrane proteins isolated from Mycoplasma penetrans.
    Zeng YH; Wu YM; Zhang WB; Yu MJ; Zhu CM; Tan LZ
    Chin Med J (Engl); 2004 Jul; 117(7):997-1001. PubMed ID: 15265371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable number of tandem aminoacid repeats in adhesion-related CDS products in Mycoplasma hyopneumoniae strains.
    de Castro LA; Rodrigues Pedroso T; Kuchiishi SS; Ramenzoni M; Kich JD; Zaha A; Henning Vainstein M; Bunselmeyer Ferreira H
    Vet Microbiol; 2006 Sep; 116(4):258-69. PubMed ID: 16730926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic variation of Mycoplasma gallisepticum, as detected by use of monoclonal antibodies.
    Panangala VS; Morsy MA; Gresham MM; Toivio-Kinnucan M
    Am J Vet Res; 1992 Jul; 53(7):1139-44. PubMed ID: 1497181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.